This study was to assess the effect of fermented rapeseed meal (FRSM) in the diet of sows, taking into account the physiological period (pregnancy or lactation) and reproductive cycle (primiparous or multiparous sows), on production performance, nutrient digestibility, colostrum immunoglobulin content, and microbial flora in sows. The experimental material included 30 primiparous gilts and 30 multiparous sows after their second lactation. The animals in the control groups CG (gilts) and CS (sows) received a standard diet for pregnant or lactating sows, depending on the reproductive period. Experimental groups EG and ES comprised gilts and multiparous sows, respectively, receiving a diet with a 4% share of FRSM in place of soybean meal up to 100 d of gestation. In addition, from 100 d of gestation to 7 d of lactation, the sows in experimental groups received a diet with a 9% share of FRSM, and then again a diet with a 4% share of FRSM until the end of lactation. The addition of 4% to 9% share of a FRSM component in feed significantly improves production parameters, mainly in primiparous gilts, leading to an increase in litter size and in litter weight at 28 d of age. It also helps to improve the digestibility of crude protein, fat, and crude fiber, and positively affects the gut microbiota of sows. Fermentation of rapeseed meal is an effective way to reduce anti-nutrients and to increase the level of lactic acid in the diet. It also stimulates the immune system, which improves piglet health, reducing the severity of diarrhoea and mortality.
The aim of the study was to analyze how per os application of hydrocolloids of silver nanoparticles (22 nm) and lipid-coated silver nanoparticles (5 nm) affect the immune, redox, and lipid status of the blood of broiler chickens. The experiment was conducted on 60 chickens. The first group was the control (Group C). The chickens in Group II received a silver nanoparticle hydrocolloid (Ag-nano) at a dose of 5 mg/kg body weight (BW) per day. The chickens in Group III received a lipid-coated silver nanoparticle hydrocolloid (AgLnano) at a dose of 5 mg/kg BW per day. Blood for analysis was collected from 24-and 38-day-old chickens and several blood parameters were determined. The increase in phagocytosis and in the metabolic activity of leukocytes observed following per os administration of chemically synthesized silver nanoparticles differing in size and in the presence or absence of a lipid coating may indicate a developing inflammatory state in the organism. The decrease in haemoglobin content and antioxidant enzyme activity and the increase in the content of iron, bilirubin, and lipid peroxidation products are indicative of oxidative stress, although in the case of administration of AgL-nano the oxidation effect appears to be greater. Administration of silver nanoparticles to the chickens, particularly 5 nm lipid-coated nanoparticles, probably led to a disturbance in protein catabolism in the organism, which is evidenced by the decrease in the activity of the liver enzymes AST and ALT and the decreased concentration of the main protein metabolism products (creatinine and urea).
The aim of the study was to analyse how per os application of hydrocolloids of silver nanoparticles (22 nm) and lipid-coated nanosilver hydrocolloids (5 nm) affect the microbiological status and morphology of the jejunum of broiler chickens and their growth performance. The experiment was conducted on 60 chickens. The first group was the control. The chickens in group II received a silver nanoparticle hydrocolloid (ag-nano) at a dose of 5 mg/kg b.w./day. The chickens in group iii received a lipid-coated nanosilver hydrocolloid (agl-nano) at a dose of 5 mg/kg b.w./day. samples of digesta were taken from the jejunum during dissection and the total numbers of fungi, aerobic bacteria and bacteria of the coli group were determined in the samples. samples of the jejunum were also collected during dissection to determine the length of the villi and depth of the crypts. The silver nanoparticles had no effect on growth performance or the histological picture of the jejunum. an increase was noted in the total number of aerobic mesophilic bacteria and a decrease in the number of coli group bacteria, which are facultative anaerobes, which indicates that the nanosilver had a selective effect on the microflora of the digestive tract in the chickens.
The present study was conducted to determine the effect of the use of varying amounts of fermented rapeseed meal in diets for rabbits on the immune status and microbiota of segments of the GIT. Forty 35 day old rabbits used in the experiment were assigned to four groups: the control group (group C) were fed a standard diet and the experimental received 4%, 8% or 12% fermented rapeseed meal (included in place of standard soybean meal). Class A, G and M immunoglobulins were determined in the blood plasma. In the food content collected after slaughter, microbiological parameters were determined for individual sections of the digestive tract. Rabbits from the groups receiving a diet with an increased proportion of fermented rapeseed meal (8% or 12%) had lower concentrations of anaerobic bacteria and Escherichia coli in the intestinal contents. Research has shown that the increase in intake of fermented rapeseed meal was correlated with an increase in the correlations between the immunoglobulin level and the size of the microbial population in the GIT. In light of the presented results fermented rapeseed meal, by supplying valuable bioactive substances, appears to be a good component in the diet of rabbits, enhancing immune system development and helping to prevent disturbances of the gut microbiota.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.